DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering.
Oliver Sandys1, Pieter C F Stokkers2, Anje A Te Velde3
1Tytgat Institute for Liver and Intestinal Research, AmsterdamUMC, AGEM, University of Amsterdam, Amsterdam, The Netherlands.
Current inflammatory bowel disease (IBD) treatments targeting single pathways show limited efficacy. A comprehensive approach addressing environmental factors alongside immunity is needed for effective IBD management.
Area of Science:
- Gastroenterology and Immunology
- Inflammation Research
- Environmental Health
Background:
- Current therapies for inflammatory bowel diseases (IBD) targeting cytokines or immune cell trafficking achieve only ~40% efficacy.
- IBD is a multifactorial condition influenced by genetics, immune responses, and environmental factors like diet and pollution.
- Existing treatments often fail to resolve the underlying inflammatory microenvironment, leading to chronic disease.
Purpose of the Study:
- To propose a comprehensive therapeutic strategy for IBD that addresses its multifactorial nature.
- To highlight the importance of environmental factors in IBD pathogenesis and treatment.
- To advocate for a multi-scalar approach targeting innate immunity, adaptive immunity, and the microenvironment.
Main Methods:
- Review of current IBD therapeutic strategies and their limitations.
- Analysis of the interplay between genetic background, immune cells, and environmental factors in IBD.
- Hypothesis formulation for a multi-target intervention strategy.
Main Results:
- Single-target therapies are insufficient due to the complexity and variability of IBD.
- Environmental factors, including diet and pollution, significantly contribute to the inflammatory milieu.
- Activation of pathways like the NLRP3 inflammasome is amplified by danger- and microbe-associated molecular patterns (D/MAMPs).
Conclusions:
- Successful IBD interventions require simultaneous targeting of innate immunity, adaptive immunity, microbiota, and environmental factors.
- A holistic approach addressing inflammation across nano-, meso-, and microscales is necessary.
- Adapting the 'DAMPing' (micro)environment is crucial for comprehensive IBD treatment.
More Related Videos
03:42Author Spotlight: Advancing Place-Based Biochar Production for Ecosystem Restoration and Soil Health
Published on: April 5, 2024
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Prevention of Further Absorption of Poison
